Differential IL-10 receptor gene expression in acute versus chronic atopiceczema. Modulation by immunosuppressive drugs and cytokines in normal cultured keratinocytes
A. Muschen et al., Differential IL-10 receptor gene expression in acute versus chronic atopiceczema. Modulation by immunosuppressive drugs and cytokines in normal cultured keratinocytes, INFLAMM RES, 48(10), 1999, pp. 539-543
Objective and Design: The effects of the anticytokine interleukin 10 (IL-10
) are mediated by specific receptors. In this study we examined the role of
the IL-10 receptor (IL-10R) in the pathophysiology of atopic eczema.
Materials and Methods: For this purpose we analyzed the expression of IL-10
R in the skin of patients with acute and chronic atopic eczema in compariso
n to the expression in healthy individuals using in situ binding experiment
s with fluorescently labeled IL-10 and semiquantitative reverse transcripta
se-PCR specific for IL-10R1. In addition, we studied the influence of the T
h2-associated cytokine interleukin-4 (IL-4), the Th1-associated gamma-inter
feron (IFN-gamma), the immunosuppressive drug FK506, the H1-antagonist lora
tadine and WA irradiation on the expression of IL-10R1 in cultured normal h
uman keratinocytes.
Results: We found that IL-10 receptor mRNA and protein are strongly downreg
ulated in acute phase atopic lesions. Furthermore we could show that IL-4,
IFN-gamma, FK506, loratadine and UVA enhance the mRNA levels of the IL-10R1
in vitro in normal cultured keratinocytes, We could also demonstrate resto
red IL-10R1 mRNA levels in lesional atopic skin of a patient after UVA1 the
rapy,
Conclusions: Our results demonstrate for the first time that IL-10 receptor
s may have a role in the pathogenesis of atopic eczema and its upregulation
by FK506 and UVA could explain the therapeutic efficacy of these agents.